改良Dixon MRI技术用于肝脏疾病肝脂肪定量的可行性:以MRS和組織學驗證
研究纳入2014年11月至2015年9月间的85名成人,评估MRI质子密度脂肪分数(PDFF)以MRS和組織學為參考估計肝脂肪分數的可行性。全肝MRI-PDFF與MRS-PDFF相關性良好(r=0.961),與組織學脂肪變程度相關(σ=0.809)。肝脂肪分數在肝葉和肝段間存在差異,右葉平均PDFF及PDFF範圍高於左葉,而右葉變異性低於左葉。
要点
- 全肝MRI-PDFF与MRS-PDFF相关性良好(r=0.961),与组织学脂肪变程度相关(σ=0.809)。
- 肝脂肪分数在肝叶和肝段间存在差异,右叶平均PDFF及PDFF范围高于左叶。
- 右叶变异性低于左叶,纵向监测时测量右肝脂肪分数可能更精确。
核心结论
- MRI-PDFF是一种准确的无创方法,可用于各种肝脏疾病的肝脂肪定量;在纵向监测中,测量右肝脂肪分数可能更精确,同时避免测量左肝脂肪分数。
研究设计与样本
- 2014年11月至2015年9月间纳入85名成人(48名男性,47名女性),其中接受MRI-PDFF者n=139、MRS-PDFF者n=49、肝活检者n=29;数据采用线性回归比较。
诊断标准与关键数值
- 全肝MRI-PDFF与MRS-PDFF相关性r=0.961。
- 全肝MRI-PDFF与组织学肝脂肪变程度相关性σ=0.809。
临床应用与阅片要点
- 作者认为,MRI-PDFF可用于各种肝脏疾病的肝脂肪定量,为无创且准确的方法。
- 作者认为,纵向监测时测量右肝脂肪分数可能更精确,同时避免测量左肝脂肪分数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess the feasibility of proton density fat fraction (PDFF) MRI for estimating hepatic fat fraction with magnetic resonance spectroscopy (MRS) and histology as references and to investigate intrahepatic fat distribution and variability.
METHODS: Between November 2014 and September 2015, 85 adults (48 males, 47 females) who underwent MRI-PDFF (n = 139), MRS-PDFF (n = 49) and liver biopsy (n = 29) were enrolled in this study. Data were compared using linear regression. MRI-PDFF and standard deviations (variability) and differences between maximum and minimum PDFF (PDFF range) for whole liver, the lobes, and segment levels were calculated for each subject.
RESULTS: Whole-liver MRI-PDFF showed good correlation with MRS-PDFF (r = 0.961) and histologic degree of hepatic steatosis (σ = 0.809). Hepatic fat fraction is different between lobes and segments. Mean PDFF and mean PDFF range of the right lobe were higher than for the left lobe, whereas variability in the right lobe was lower than in the left lobe.
CONCLUSION: MRI-PDFF is an accurate non-invasive method for quantifying hepatic fat for various hepatic disorders, and may be preferable for measuring fat fraction in the right liver for more precise values in longitudinal monitoring, while avoiding FF measurement in the left liver. Advances in knowledge: MRI-PDFF provides a non-invasive and accurate quantification of hepatic steatosis in various hepatic disorders. It would be preferable to measure FF in the right liver than in the left liver.
引用
- Kang BK, Kim M, Song SY, et al. Feasibility of modified Dixon MRI techniques for hepatic fat quantification in hepatic disorders: validation with MRS and histology. Br J Radiol. 2017. PMID: 29022777. doi:10.1259/bjr.20170378
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。